Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bromelain + quercetin is a dietary supplement combining two natural compounds—bromelain, a proteolytic enzyme derived from pineapple stems, and quercetin, a plant-derived flavonoid. This combination is primarily used for its synergistic anti-inflammatory and antihistamine effects. Quercetin acts as an antioxidant and stabilizes mast cells to inhibit the release of histamine, thereby reducing allergy symptoms such as runny nose and itchy eyes. Bromelain enhances the absorption of quercetin in the body while also providing its own anti-inflammatory benefits by inhibiting inflammatory mediators like prostaglandins. Together, they support immune health, reduce inflammation (including in conditions like arthritis or sinusitis), promote respiratory comfort during allergy seasons or environmental challenges, and may offer additional antiviral properties[2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bromelain + quercetin.